TP53 and neoplasm: 478 tumor samples and 44 normal samples from TCGA HNSCC cohort for whom both miRNA and mRNA sequencing was available. The dataset included 391HPV- and 85 HPV+ cases, with 331 p53 mutated and 147 p53 wild type cases respectively. 352 out of 478 samples were male and 126 female.